Ubs Oconnor LLC Hille Vax, Inc. Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 51,779 shares of HLVX stock, worth $97,862. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,779

Holding current value

$97,862

% of portfolio

0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.58 - $14.42 $7,598 - $69,345	4,809 Added 10.24%	51,779 $91,000
Q2 2024 Aug 14, 2024	BUY	$11.86 - $15.93 $15,346 - $20,613	1,294 Added 2.83%	46,970 $679,000
Q1 2024 May 15, 2024	SELL	$14.15 - $19.75 $217,669 - $303,814	-15,383 Reduced 25.19%	45,676 $759,000
Q4 2023 Feb 14, 2024	SELL	$10.35 - $17.11 $552,886 - $913,999	-53,419 Reduced 46.66%	61,059 $979,000
Q3 2023 Nov 14, 2023	BUY	$11.59 - $16.7 $394,060 - $567,800	34,000 Added 42.25%	114,478 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.76 $1.04 Million - $1.51 Million	80,478 New	80,478 $1.38 Billion
Q1 2023 May 15, 2023	BUY	$14.73 - $18.18 $27,987 - $34,542	1,900 Added 2.39%	81,267 $1.34 Million
Q4 2022 Feb 14, 2023	BUY	$13.52 - $21.46 $249,092 - $395,379	18,424 Added 30.23%	79,367 $0
Q3 2022 Nov 14, 2022	SELL	$10.5 - $22.01 $315,000 - $660,300	-30,000 Reduced 32.99%	60,943 $1.04 Billion
Q2 2022 Aug 12, 2022	BUY	$8.7 - $20.18 $791,204 - $1.84 Million	90,943 New	90,943 $994,000

Others Institutions Holding HLVX

# of Institutions

Shares Held

36.3M

Call Options Held

Put Options Held

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.6M
Shares

$20.1 Million
1.01% of portfolio
Tang Capital Management LLC San Diego, CA

4.92M
Shares

$9.3 Million
0.74% of portfolio
Black Rock Inc. New York, NY

2.09M
Shares

$3.95 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

1.96M
Shares

$3.7 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.88M
Shares

$3.56 Million
0.06% of portfolio

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $63.2M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account